With our GLP-1 Weight Management program, you can speak to a healthcare provider and receive your medication for just $297 per month with no insurance needed
The medications - semaglutide (Wegovy), liraglutide (Saxenda), and tirzepatide (Zepbound) - are backed by science and stunning accounts of people losing as much as 20% of their body weight
Not the versions marketed as oral Mounjaro. Not the tirzepatide pill forms are circulating without clinical backing
Although this medication was originally designed for type 2 diabetes and weight management, its classification as a GLP-1 agonist has sparked discussions about potential off-label benefits, particularly in the realm of neurodevelopmental disorders like ADHD
Lie MRKL, van der Giessen J, Fuhler GM, de Lima A, Peppelenbosch MP, van der Ent C, van der Woude CJ